LOGO
LOGO

LENSAR Gains Market Share In Growing Cataract Surgery Space - Keep An Eye On This Stock

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Cataract, which causes clouding of the lens, is the leading cause of vision loss in the United States. According to the CDC, an estimated 20.5 million (17.2%) Americans aged 40 years and older have cataracts in one or both eyes, and 6.1 million (5.1%) have had their lens removed by surgery. Roughly 32 million cataract surgeries were conducted worldwide in 2024. As per the NIH, 38.7 million people will have cataracts by 2030.

The stock we are bringing to your attention today is that of a commercial-stage medical device company and an innovator in laser cataract surgery - LENSAR Inc. (LNSR).

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update -June 15 - June 19, 2026

June 19, 2026 16:46 ET
Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.